Social Media and Pharmacovigilance
Mark Senak, author of the EyeonFDA blog and social media enthusiast, posted a great piece about pharma’s reluctance to adopt social media and the changes in adverse event reporting-- aka pharmacovigilance--requirements that may change this attitude.
Hat tip to Mark!
Until next time...
Good Luck and Good Job Hunting

